Bexsero | search
Click here to view Bexsero news from 60+ newspapers.
Bookmark or Share- Vaccines for Meningococcal | CDCSerogroup B meningococcal or MenB vaccines (Bexsero ® and Trumenba ®) Pentavalent meningococcal or MenABCWY vaccine (Penbraya TM) All 11 to 12 year olds should get a MenACWY vaccine, with a booster dose at 16 years old. Teens and young adults (16 through 23 years old) also may get a MenB vaccine.
- Bexsero | The Australian Immunisation HandbookDescription: Registered for use in people aged ≥2 months. MenB-MC — recombinant multicomponent meningococcal serogroup B vaccine. Each 0.5 mL monodose pre-filled syringe contains: 50 µg Neisseria meningitidis serogroup B Neisseria heparin binding antigen fusion protein.
- Where to Get the Meningitis B Vaccine | BEXSEROBEXSERO is the only meningitis B vaccine that can be completed in as fast as one month with just two doses. Talk to your teen’s healthcare provider about vaccination with BEXSERO. WHERE TO GET BEXSERO. Vaccines subject to availability. State, age and health-related restrictions may apply.
- Frequently Asked Questions About Meningitis B | BEXSEROBEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B and is approved for use in individuals 10 through 25 years of age. BEXSERO is the only meningitis B vaccine that can be completed in as fast as 1 month with just 2 doses.
- Bexsero: Dosage, side effects, similar drugs, and more - Medical News TodayBexsero is a brand-name intramuscular injection. Doctors prescribe it to help prevent meningitis B. Bexsero belongs to the vaccine drug class. Bexsero is FDA-approved to help prevent...
More
